See more : ScoutCam Inc. (SCTC) Income Statement Analysis – Financial Results
Complete financial analysis of RMH Holdings Limited (8437.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of RMH Holdings Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Shihlin Paper Corporation (1903.TW) Income Statement Analysis – Financial Results
- American Shared Hospital Services (AMS) Income Statement Analysis – Financial Results
- Argenica Therapeutics Limited (AGN.AX) Income Statement Analysis – Financial Results
- Rainbow International Corp. (RNBI) Income Statement Analysis – Financial Results
- City Online Services Limited (CITYONLINE.BO) Income Statement Analysis – Financial Results
RMH Holdings Limited (8437.HK)
About RMH Holdings Limited
RMH Holdings Limited, an investment holding company, provides medical, dermatological, and aesthetic products and services in Singapore, Hong Kong, and internationally. The company operates in two segments, Healthcare service and Trading sales. It provides specialty care services for various dermatological conditions affecting skin, hair, and nails through medical, surgical, laser, and aesthetic treatments. The company also engages in treating skin cancer and skin diseases, such as eczema, psoriasis, acne, pigmentation, adverse drug reactions, and warts; and providing consultancy, prescription, and dispensing services. In addition, it engages in the trading of health supplement products and medical products, including hand sanitizers, disposal medical masks, and other medical products. The company operates seven dermatology and surgery clinics, one aesthetic and laser center, one multi-specialists center, and one regenerative medicine center. RMH Holdings Limited was incorporated in 2017 and is headquartered in Singapore.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.18M | 4.24M | 10.29M | 7.81M | 7.23M | 6.99M | 7.05M | 6.16M | 5.60M |
| Cost of Revenue | 4.00M | 3.53M | 2.28M | 2.69M | 1.31M | 1.20M | 108.00K | 100.00K | 86.00K |
| Gross Profit | -820.00K | 707.00K | 8.01M | 5.12M | 5.91M | 5.79M | 6.95M | 6.06M | 5.51M |
| Gross Profit Ratio | -25.79% | 16.67% | 77.84% | 65.62% | 81.84% | 82.87% | 98.47% | 98.38% | 98.46% |
| Research & Development | 0.00 | 0.00 | 0.00 | 92.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | -427.00K | 1.50M | 1.18M | 1.02M | 1.43M | 1.09M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.33M | 1.67M | 742.00K | -427.00K | 1.50M | 1.18M | 1.02M | 1.43M | 1.09M |
| Other Expenses | 0.00 | 7.70M | 16.01M | 10.31M | 4.26M | 2.56M | -2.93M | 0.00 | 0.00 |
| Operating Expenses | 2.33M | 7.70M | 16.01M | 9.89M | 5.76M | 3.74M | 4.09M | 2.93M | 2.77M |
| Cost & Expenses | 6.33M | 11.24M | 18.29M | 12.57M | 7.07M | 4.94M | 4.20M | 3.03M | 2.85M |
| Interest Income | 0.00 | 1.00K | 46.00K | 42.00K | 290.00K | 169.00K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 55.00K | 218.00K | 340.00K | 261.00K | 65.00K | 0.00 | 16.00K | 8.00K | 7.00K |
| Depreciation & Amortization | 1.80M | 3.76M | 3.76M | 2.70M | 1.39M | 158.00K | 192.00K | 221.00K | 215.00K |
| EBITDA | -5.00M | -7.84M | -2.59M | -6.47M | 1.83M | 2.29M | 118.00K | 3.27M | 2.80M |
| EBITDA Ratio | -157.08% | -67.11% | -31.88% | -31.23% | 25.31% | 32.76% | 1.67% | 54.42% | 52.89% |
| Operating Income | -3.15M | -6.60M | -7.04M | -5.14M | 444.00K | 2.05M | 2.86M | 3.05M | 2.59M |
| Operating Income Ratio | -99.03% | -155.72% | -68.38% | -65.78% | 6.15% | 29.28% | 40.53% | 49.55% | 46.21% |
| Total Other Income/Expenses | -3.70M | -8.94M | -1.03M | -4.43M | -3.21M | -1.40M | -2.95M | -8.00K | -798.00K |
| Income Before Tax | -6.85M | -13.13M | -8.87M | -9.20M | 379.00K | 2.13M | -90.00K | 3.04M | 2.58M |
| Income Before Tax Ratio | -215.50% | -309.53% | -86.22% | -117.77% | 5.25% | 30.50% | -1.28% | 49.42% | 46.09% |
| Income Tax Expense | 0.00 | 11.83M | -86.00K | 75.00K | 221.00K | 280.00K | 380.00K | 363.00K | 328.00K |
| Net Income | -6.75M | -24.95M | -8.79M | -9.27M | 158.00K | 1.85M | -470.00K | 2.68M | 2.25M |
| Net Income Ratio | -212.23% | -588.40% | -85.38% | -118.73% | 2.19% | 26.49% | -6.66% | 43.52% | 40.23% |
| EPS | -0.01 | -0.02 | -0.01 | -0.02 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| EPS Diluted | -0.01 | -0.02 | -0.01 | -0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 1.33B | 1.17B | 954.95M | 600.01M | 600.76M | 609.68M | 480.08M | 451.16M | 451.16M |
| Weighted Avg Shares Out (Dil) | 1.33B | 1.17B | 954.95M | 609.68M | 609.68M | 609.68M | 487.74M | 609.68M | 609.68M |
Source: https://incomestatements.info
Category: Stock Reports